Epidemiology of ANCA-associated Vasculitis

Rheumatic Disease Clinics of North America

Volumn 36, Issue 3, 2010, Pages 447-461

  Ntatsaki, Eleana ^a   Watts, Richard A ^a,b   Scott, David G I ^b,c  

^a IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

ANCA associated vasculitis; Churg Strauss syndrome; Epidemiology; Microscopic polyangiitis; Polyarteritis nodosa; Vasculitis; Wegener's granulomatosis

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; HLA DPB1 ANTIGEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

AGE DISTRIBUTION; ANCA ASSOCIATED VASCULITIS; CHURG STRAUSS SYNDROME; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; ETHNICITY; GENETICS; GEOGRAPHY; HUMAN; IMMUNOPATHOGENESIS; INCIDENCE; INFECTION; MICROSCOPIC POLYANGIITIS; OCCUPATION; POLYARTERITIS NODOSA; PREVALENCE; PRIORITY JOURNAL; REVIEW; TIME; WEGENER GRANULOMATOSIS;

AGE OF ONSET; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; AUSTRALIA; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; PREVALENCE; UNITED STATES;

EID: 77955255417     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2010.04.002     Document Type: Review

References (68)

1. Hunder G.G., Bloch D.A., Michel B.A., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990, 33(8):1122-1128.
2. Jennette J.C., Falk R.J., Andrassy K., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37(2):187-192.
3. Watts R.A., Jolliffe V.A., Carruthers D.M., et al. Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangiitis. Arthritis Rheum 1996, 39(7):1208-1212.
4. Watts R.A., Lane S., Hanslik T., et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007, 66(2):222-227.
5. Liu L.J., Chen M., Yu F., et al. Evaluation of a new algorithm in classification of systemic vasculitis. Rheumatology (Oxford) 2008, 47(5):708-712.
6. Ormerod A.S., Cook M.C. Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales. Intern Med J 2008, 38(11):816-823.
7. Gonzalez-Gay M.A., Garcia-Porrua C., Guerrero J., et al. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions. Arthritis Rheum 2003, 49(3):388-393.
8. Watts R.A., Mooney J., Scott D.G.I., et al. A twenty year study of the epidemiology of ANCA associated vasculitis in UK [abstract]. APMIS Suppl 2009, 117(Suppl 127):159.
9. Panagiotakis S.H., Perysinakis G.S., Kritikos H., et al. The epidemiology of primary systemic vasculitides involving small vessels in Crete (southern Greece): a comparison of older versus younger adult patients. Clin Exp Rheumatol 2009, 27(3):409-415.
10. Mohammad A.J., Jacobsson L.T., Westman K.W., et al. Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford) 2009, 48(12):1560-1565.
11. Watts R.A., Al-Taiar A., Scott D.G., et al. Prevalence and incidence of Wegener's granulomatosis in the UK general practice research database. Arthritis Rheum 2009, 61(10):1412-1416.
12. Godman G.C., Churg J. Wegener's granulomatosis: pathology and review of the literature. AMA Arch Pathol 1954, 58(6):533-553.
13. Gardner-Medwin J.M., Dolezalova P., Cummins C., et al. Incidence of Henoch Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 2002, 360(9341):1197-1202.
14. Grisaru S., Yuen G.W., Miettunen P.V., et al. Incidence of Wegener's granulomatosis in children. J Rheumatol 2010, 37(2):440-442.
15. Andrews M., Edmunds M., Campbell A., et al. Systemic vasculitis in the 1980's - is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis?. J R Coll Physicians Lond 1990, 24(4):284-288.
16. Takala J.H., Kautiainen H., Malmberg H., et al. Incidence of Wegener's granulomatosis in Finland 1981-2000. Clin Exp Rheumatol 2008, 26(3 Suppl 49):S81-S85.
17. Koldingsnes W., Nossent J.C. Epidemiology of Wegener's granulomatosis in northern Norway. Arthritis Rheum 2000, 43(11):2481-2487.
18. Reinhold-Keller E., Herlyn K., Wagner-Bastmeyer R., et al. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 2005, 53(1):93-99.
19. Knight A., Ekbom A., Brandt L., et al. Increasing incidence of Wegener's granulomatosis in Sweden, 1975-2001. J Rheumatol 2006, 33(10):2060-2063.
20. Haugeberg G., Bie R., Bendvold A., et al. Primary vasculitis in a Norwegian community hospital: a retrospective study. Clin Rheumatol 1998, 17(5):364-368.
21. Westman K.W., Bygren P.G., Olsson H., et al. Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 1998, 9(5):842-852.
22. González-Gay M.A., García-Porrúa C. Systemic vasculitis in adults in northwestern Spain 1988-97. Clinical and epidemiological aspects. Medicine (Baltimore) 1999, 78(5):292-308.
23. Dadoniene J., Kirdaite G., Mackiewicz Z., et al. Incidence of primary systemic vasculitis in Vilnius: a university hospital population based study. Ann Rheum Dis 2005, 64(2):335-336.
24. Zeft A., Schlesinger M., Weiss N., et al. Case control study of ANCA associated vasculitis in western Montana [abstract]. Arthritis Rheum 2005, 52(Suppl):S648.
25. Hissaria P., Cai F.Z., Ahern M., et al. Wegener's granulomatosis: epidemiological and clinical features in a South Australian study. Intern Med J 2008, 38(10):776-780.
26. Sanchez A.A., Acevedo E.M., Sanchez C.G., et al. Evaluation of epidemiology of the primary systemic vasculitides in a Latin-American well-defined population [abstract]. Arthritis Rheum 2006, 54(Suppl):S757.
27. Watts R.A., Gonzalez-Gay M., Garcia-Porrua C., et al. Geoepidemiology of systemic vasculitis. Ann Rheum Dis 2001, 60(2):170-172.
28. Reinhold-Keller E., Zeidler A., Gutfleisch J., et al. Giant cell arteritis is more prevalent in urban than rural populations: results of an epidemiological study of primary systemic vasculitides in Germany. Rheumatology (Oxford) 2000, 39(12):1396-1402.
29. Cotch M.F., Hoffman G.S., Yerg D.E., et al. The epidemiology of Wegener's granulomatosis: estimates of the five year period prevalence, annual mortality and geographic disease distribution from population based data sources. Arthritis Rheum 1996, 39(1):87-92.
30. Watts R.A., Scott D.G., Jayne D.R., et al. Renal vasculitis in Japan and the UK-are there differences in epidemiology and clinical phenotype?. Nephrol Dial Transplant 2008, 23(12):3928-3931.
31. Gibson A., Stamp L.K., Chapman P.T., et al. The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. Rheumatology (Oxford) 2006, 45(5):624-628.
32. O'Donnell J.L., Stevanovic V.R., Frampton C., et al. Wegener's granulomatosis in New Zealand: evidence for a latitude-dependent incidence gradient. Intern Med J 2007, 37(4):242-246.
33. Malaviya A.N., Kumar A., Singh Y.N., et al. Wegener's granulomatosis in India: not so rare. Br J Rheumatol 1990, 29(6):499-500.
34. Mahr A.D., Neogi T., Merkel P.A. Epidemiology of Wegener's granulomatosis: lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol 2006, 24(2 Suppl 41):S82-S91.
35. Mahr A., Guillevin L., Poissonnet M., et al. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 2004, 51(1):92-99.
36. Fujimoto S., Uezono S., Hisanaga S., et al. Incidence of ANCA-associated primary renal vasculitis in the Miyazaki prefecture: the first population-based, retrospective, epidemiologic survey in Japan. Clin J Am Soc Nephrol 2006, 1(5):1016-1022.
37. Knight A., Sandin S., Askling J. Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease. Arthritis Rheum 2008, 58(1):302-307.
38. Heckmann M., Holle J.U., Arnig L., et al. The Wegener's granulomatosis quantitive trait locus on chromosome 6p21.3 as characterized by tagSNP genotyping. Ann Rheum Dis 2008, 67(7):972-979.
39. Raynauld J.P., Bloch D.A., Fries J.F. Seasonal variation in the onset of Wegener's granulomatosis, polyarteritis nodosa and giant cell arteritis. J Rheumatol 1993, 20(9):1524-1526.
40. Lane S.E., Watts R.A., Bentham G., et al. Are environmental factors important in primary systemic vasculitis? A case control study. Arthritis Rheum 2003, 48(3):814-823.
41. Gatenby P.A., Lucas R.M., Engelsen O., et al. Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation?. Arthritis Rheum 2009, 61(10):1417-1424.
42. Staples J.A., Ponsonby A.L., Lim L., et al. Ecologic analysis of some immune related disorders, including type I diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. Environ Health Perspect 2003, 111(4):518-523.
43. Popa E.R., Stegeman C.A., Abdulahad W.H., et al. Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis. Rheumatology (Oxford) 2007, 46(6):1029-1033.
44. Csernok E., Lamprecht P., Gross W.L. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis. Curr Opin Rheumatol 2010, 22(1):43-48.
45. Knight A., Sandin S., Askling J. Occupational risk factors for Wegener's granulomatosis - a case control study. Ann Rheum Dis 2010, 69(4):737-740.
46. Tervaert J.W., Stegeman C.A., Kallenberg C.G. Silicon exposure and vasculitis. Curr Opin Rheumatol 1998, 10(1):12-17.
47. Nuyts G.D., van Vlem E., de Vos A., et al. Wegener's granulomatosis is associated with exposure to silicon compounds: a case control study. Nephrol Dial Transplant 1995, 10(7):1162-1165.
48. Hogan S.L., Satterly K.K., Dooley M.A., et al. Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. J Am Soc Nephrol 2001, 12(1):134-142.
49. Hogan S.L., Cooper G.S., Savitz D.A., et al. Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study. Clin J Am Soc Nephrol 2007, 2(2):290-299.
50. Duna G.F., Cotch M.F., Galperin C., et al. Wegener's granulomatosis: role of environmental exposures. Clin Exp Rheumatol 1998, 16(6):669-674.
51. Pai P., Bone J.M., Bell G.M. Hydrocarbon exposure and glomerulonephritis due to systemic vasculitis. Nephrol Dial Transplant 1998, 13(5):1321-1323.
52. Albert D., Clarkin C., Komoroski J., et al. Wegener's granulomatosis: possible role of environmental agents in its pathogenesis. Arthritis Rheum 2004, 51(4):656-664.
53. Davson J., Ball J., Platt R. The kidney in periarteritis nodosa. Q J Med 1948, 17(67):175-202.
54. El-Reshaid K., Kapoor M., El-Reshaid W., et al. The spectrum of renal disease associated with microscopic polyangiitis and classical polyarteritis nodosa in Kuwait. Nephrol Dial Transplant 1997, 12(9):1874-1882.
55. Andrassy K., Erb A., Koderisch J., et al. Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome. Clin Nephrol 1991, 35(4):139-147.
56. Pettersson E.E., Sundelin B., Heigl Z. Incidence and outcome of pauci-immune necrotising glomerulonephritis in adults. Clin Nephrol 1995, 43(3):141-149.
57. Tidman M., Olander R., Svalander C., et al. Patients hospitalised because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies. J Intern Med 1998, 244(2):133-141.
58. Yashiro M., Muso E., Itoh-Ihara T., et al. Significantly high regional morbidity of MPO-ANCA-related angitis and/or nephritis with respiratory tract involvement after the 1995 great earthquake in Kobe (Japan). Am J Kidney Dis 2000, 35(5):889-895.
59. Vinit J., Muller G., Bielefeld P., et al. Churg-Strauss syndrome: retrospective study in Burgundian population in France in past 10 years. Rheumatol Int 2009, [Epub ahead of print]. PMID: 20039171.
60. Kurland L.T., Chuang T.Y., Hunder G.G. The epidemiology of systemic arteritis. The epidemiology of the rheumatic diseases 1984, 196-205. Gower Publishing, New York. R.C. Lawrence, L.E. Shulman (Eds.).
61. Guillevin L. Virus-associated vasculitides. Rheumatology (Oxford) 1999, 38(7):588-590.
62. Wechsler M., Wong D., Miller M.K., et al. Churg Strauss syndrome in patients treated with omalizumab. Chest 2009, 136(2):507-518.
63. Bibby S., Healy B., Steele R., et al. Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: an analysis of the FDA AERS database. Thorax 2010, 65(2):132-138.
64. Harrold L.R., Andrade S.E., Go A.S., et al. Incidence of Churg Strauss Syndrome in asthma drug users: a population based perspective. J Rheumatol 2005, 32(6):1076-1080.
65. Harrold L.R., Patterson M.K., Andrade S.E., et al. Asthma drug use and the development of Churg-Strauss syndrome (CSS). Pharmacoepidemiol Drug Saf 2007, 16(6):620-626.
66. Hauser T., Mahr A., Metzler C., et al. The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study. Thorax 2008, 63(8):677-682.
67. Eaton W.W., Rose N.R., Kalaydjian A., et al. Epidemiology of autoimmune diseases in Denmark. J Autoimmun 2007, 29(1):1-9.
68. Mohammad A.J., Jacobsson L.T., Mahr A.D., et al. Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 2007, 46(8):1329-1337.